152 related articles for article (PubMed ID: 9621044)
21. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 variation diminishes CD4 T lymphocyte recognition.
Harcourt GC; Garrard S; Davenport MP; Edwards A; Phillips RE
J Exp Med; 1998 Nov; 188(10):1785-93. PubMed ID: 9815256
[TBL] [Abstract][Full Text] [Related]
23. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.
Abrignani S; Montagna D; Jeannet M; Wintsch J; Haigwood NL; Shuster JR; Steimer KS; Cruchaud A; Staehelin T
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6136-40. PubMed ID: 1696717
[TBL] [Abstract][Full Text] [Related]
24. Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
Warren AP; Thomas DB
AIDS Res Hum Retroviruses; 1992 May; 8(5):559-64. PubMed ID: 1381202
[TBL] [Abstract][Full Text] [Related]
25. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
26. Attenuated Listeria monocytogenes carrier strains can deliver an HIV-1 gp120 T helper epitope to MHC class II-restricted human CD4+ T cells.
Guzmán CA; Saverino D; Medina E; Fenoglio D; Gerstel B; Merlo A; Li Pira G; Buffa F; Chakraborty T; Manca F
Eur J Immunol; 1998 Jun; 28(6):1807-14. PubMed ID: 9645361
[TBL] [Abstract][Full Text] [Related]
27. Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein.
Zhan X; Slobod KS; Surman S; Brown SA; Lockey TD; Coleclough C; Doherty PC; Hurwitz JL
J Virol; 2003 Apr; 77(7):4231-6. PubMed ID: 12634380
[TBL] [Abstract][Full Text] [Related]
28. Antigenicity of HIV-derived T helper determinants in the context of carrier recombinant proteins: effect on T helper cell repertoire selection.
Manca F; De Berardinis P; Fenoglio D; Ombra MN; Li Pira G; Saverino D; Autiero M; Lozzi L; Bracci L; Guardiola J
Eur J Immunol; 1996 Oct; 26(10):2461-9. PubMed ID: 8898961
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity in the recognition of the simian immunodeficiency virus envelope glycoprotein by CD4+ T cell clones from immunized macaques.
Jones WC; Barnard AL; Slade A; Mills KH
J Immunol; 1992 Nov; 149(9):3120-6. PubMed ID: 1383339
[TBL] [Abstract][Full Text] [Related]
30. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
31. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
[TBL] [Abstract][Full Text] [Related]
32. Induction of neutralizing antibodies against human immunodeficiency virus type 1 using synthetic peptide constructs containing an immunodominant T-helper cell determinant from vpr.
Sarobe P; Lasarte JJ; Golvano JJ; Prieto I; Gullón A; Soto MJ; Labarga P; Prieto J; Borrás-Cuesta F
J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):635-40. PubMed ID: 8207641
[TBL] [Abstract][Full Text] [Related]
33. Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site.
Utachee P; Isarangkura-na-ayuthaya P; Tokunaga K; Ikuta K; Takeda N; Kameoka M
Retrovirology; 2014 Apr; 11():32. PubMed ID: 24758333
[TBL] [Abstract][Full Text] [Related]
34. Priming with T helper cell epitope peptides enhances the antibody response to the envelope glycoprotein of HIV-1 in primates.
Hosmalin A; Nara PL; Zweig M; Lerche NW; Cease KB; Gard EA; Markham PD; Putney SD; Daniel MD; Desrosiers RC
J Immunol; 1991 Mar; 146(5):1667-73. PubMed ID: 1704401
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses.
Steers NJ; Ratto-Kim S; de Souza MS; Currier JR; Kim JH; Michael NL; Alving CR; Rao M
PLoS One; 2012; 7(8):e42579. PubMed ID: 22880042
[TBL] [Abstract][Full Text] [Related]
36. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
[TBL] [Abstract][Full Text] [Related]
37. Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques.
Shen X; Bogers WM; Yates NL; Ferrari G; Dey AK; Williams WT; Jaeger FH; Wiehe K; Sawant S; Alam SM; LaBranche CC; Montefiori DC; Martin L; Srivastava I; Heeney J; Barnett SW; Tomaras GD
J Virol; 2017 Oct; 91(19):. PubMed ID: 28490585
[TBL] [Abstract][Full Text] [Related]
38. Characterization of CD4+ T helper cell fine specificity to the envelope glycoproteins of simian immunodeficiency virus.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Med Primatol; 2002 Aug; 31(4-5):194-204. PubMed ID: 12390542
[TBL] [Abstract][Full Text] [Related]
39. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
40. Proximal glycans outside of the epitopes regulate the presentation of HIV-1 envelope gp120 helper epitopes.
Li H; Xu CF; Blais S; Wan Q; Zhang HT; Landry SJ; Hioe CE
J Immunol; 2009 May; 182(10):6369-78. PubMed ID: 19414790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
